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Summary Longterm goitrogen administration to rodents is well known to result in multiple proliferative
lesions of the thyroid. The regression of these lesions on withdrawal of goitrogen has led to their neoplastic
nature being questioned, and they have been regarded as 'nodules' rather than as true tumours. We have
induced multiple thyroid lesions by the combined use of high dose radiation as a mutagen, together with
goitrogen administration to induce prolonged TSH growth stimulation. G6PD histochemistry was used in
heterozygous G6PD deficient female mice to show that all the thyroid lesions induced by this regime were
monophenotypic, and therefore monoclonal in origin. The great majority of induced tumours were adenomas,
a minority were carcinomas. The number ofcarcinomas observed was significantly lower in a group of animals
from which goitrogen was withdrawn for 4 weeks prior to killing, when compared to animals killed while on
goitrogen treatment. Both adenomas and carcinomas, including areas of intravascular tumour, showed
morphological features of regression on withdrawal of the goitrogen. There are three key cellular changes
which must occur in spontaneous thyroid carcinogenesis - escape from a growth limiting mechanism,
acquisition of TSH independent growth and acquisition of invasiveness. In the natural selection of mutations
or epimutations during carcinogenesis, prolonged high levels of TSH are likely to remove any selective
advantage from mutations that lead to TSH independent growth. Tumours induced by a regime including
prolonged goitrogen treatment may therefore develop following two rather than three key stages. They will
occur with an increased frequency relative to lesions observed in spontaneous carcinogenesis, but will retain
TSH dependency. We speculate that several mechanisms may lead to loss of the growth limiting mechanism,
including translocation of an oncogene to the region of a TSH induced promoter. Other carcinogenic regimes
may also increase the yield of tumours by creating conditions which reduce the number of essential steps
required for carcinogenesis, and may involve translocation to a carcinogen inducible promoter.
Experimental thyroid tumours are readily induced by expos-
ing the thyroid to a mutagen, commonly radiation, followed
by longterm treatment with a goitrogen (Doniach, 1974).
This regime consistently produces many benign lesions and a
minority of lesions classified as carcinomas on the basis of
vascular invasion and metastasis. A smaller number of
tumours can be induced by longterm goitrogen administra-
tion alone without any initial mutagen treatment. Both fac-
tors involved, the radiation and the prolonged high levels of
thyroid stimulating hormone (TSH) induced by goitrogen
therapy, are known to be important in human thyroid car-
cinogenesis.
Early studies using longerm goitrogen treatment to induce
benign thyroid lesions showed that repeated transplantation
to thyroid hormone deficient hosts could lead to the develop-
ment of malignancy (Purves et al., 1951; Morris & Green,
1951). Initial transplantation of tumours induced by goitro-
gen treatment to normal hosts were unsuccessful, suggesting
that the benign lesions were TSH dependent. However, after
sequential transplantation in goitrogen-treated hosts some
tumours were able to grow on transplantation to normal rats
(Wollman, 1963), demonstrating that TSH independent
growth had developed. Later studies using similar techniques
have found that a cellular, differentiated tumour derived
from a rat maintained for 18 months on a low iodide diet
could produce normal follicular architecture when implanted
into an iodide-sufficient host (Matovinovic et al., 1970).
The finding that withdrawal of the goitrogen may lead to
regression of the thyroid proliferative lesions induced by
these techniques - including thyroid deposits in the lungs
(Jemec, 1977) - has led to the suggestion that these are
hyperplastic lesions which should not be regarded as true
tumours (Todd, 1986). While this may be thought to be a
matter of semantics, the reversibility of the malignant
phenotype is a topic of general importance. In addition, the
increasingly frequent finding of thyroid lesions in toxicity
testing (Thomas & Williams, in press) makes this an impor-
tant question in assessing carcinogenic potential.
We have developed a method for assessing the clonal
origin of tumours at a cellular level using X-linked enzyme
histochemistry. Applying this to thyroid tumours induced by
low dose radiation and prolonged goitrogen treatment in the
heterozygous glucose-6-phosphate dehydrogenase (G6PD)
deficient mouse, we have shown that two types of benign
thyroid proliferations can be identified (Thomas et al., 1989).
The adenoma, which is typically encapsulated or sharply
circumscribed, and composed of monomorphic epithelium,
shows epithelial monoclonality. The nodule, which is less
frequent, is typically non-encapsulated, and composed of
polymorphic epithelium and a prominent stromal compon-
ent, and shows epithelial polyclonality. While hyperplasias
are generally accepted as polyclonal, a sharply circumscribed
epithelial lesion which is derived from a single cell shows at
least some of the features of neoplasia. We therefore set out
to induce demonstrably monoclonal thyroid lesions by high
dose radiation followed by longterm goitrogen treatment and
to ascertain whether monoclonal thyroid lesions showed
regression on withdrawal of the high levels of circulating
TSH.
Materials and methods
Animals
Breeding pairs of the GPDX strain of mice were kindly
donated by Dr M.F. Lyon, MRC Harwell, UK. This strain
of mouse exhibits erythrocyte G6PD activity 15, 20 and 60%
of normal in the homo-, hemi-, and heterozygote respectively
(Pretsch et al., 1988) as expected for an X-linked defect. The
animals were crossbred with mice of the C3H strain,
homozygous for normal levels of G6PD, to produce female
heterozygous C3H x GPDX mice. All animals were main-
tained in our own Animal Unit and fed normal Rat and
Mouse Breeding Diet (Pilsbury's Ltd., Edgbaston, UK) and
tap water ad libitum, unless otherwise stated
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Induction ofthyroid lesions
Fifty-six female mice (18 homozygous and 20 heterozygous
for deficient G6PD activity, and 18 normal female C3H mice)
were given a single intraperitoneal injection of 131I (specific
activity 6-20 mCi .tg'-) in 0.1 ml saline at 3 weeks of age.
Half of the animals in each group were given 11 pCi, and
half 23 jCi. One week later goitrogen administration in the
drinking water was commenced. Mice are relatively resistant
to the goitrogenic effect of aminotriazole; we have found that
a combination of 0.2% aminotriazole and 0.5% sodium per-
chlorate, sweetened with 0.5% sucrose is both palatable and
a consistently effective goitrogen.
After 46 weeks, half of the mice receiving each radiation
dose were killed by CO2 inhalation. The goitrogen regime
was withdrawn from the remaining 28, which were given
normal tap water for a further period of 4 weeks until
sacrifice.
Assessment oflesions
Thyroids were snap frozen in dry ice-cooled isopentane and
sectioned in a cryostat. Two serial frozen sections (6 jim)
were cut at 100 jim intervals through the gland, one stained
with haematoxylin and eosin and one with the histochemical
technique for G6PD. Briefly, sections are incubated in media
containing glucose-6-phosphate and NADP as susbtrates.
The reaction product of the enzyme is visualised by reduction
of nitroblue tetrazolium (see Thomas et al., 1989). Numerous
lesions were found, and only those present in the median
section through the gland were assessed for quantitation.
None showed the features of nodules; all were classified as
either adenoma or carcinoma. Clear evidence of extracap-
sular vascular invasion was present in all the carcinomas.
Results
No significant difference with respect to number and type of
tumours was observed between the groups of mice given
11 iCi and those given 23 jiCi 1311. There were no intercur-
rent deaths in either group of animals.
Animals maintained on goitrogen prior to sacrifice
Multiple lesions were observed in all animals. A total of 98
lesions were counted (Table I), the average number of lesions
per animal being 3.5 ± 2.1 (range 1-1 1). Ofthese, 84 showed
the morphological characteristics of adenomas - sharply cir-
cumscribed or encapsulated lesions, lacking any evidence of
invasion. They were cellular tumours with small follicles or
trabeculae showing scanty or absent colloid. The tumour
Table I Effect of the withdrawal of TSH stimulation on number
and type of thyroid lesion
Tumour number
Tumour type Goitrogen groupa Withdrawal groupb
Adenoma 84 71
Carcinoma 14* 2*
Total 98 73
a28 animals maintained on goitrogen for 46 weeks; b28 animals
from whom goitrogen was withdrawn for four weeks after 46 weeks
of treatment; *x2: P <0.01.
Table II G6PD phenotype of thyroid lesions induced in
C3H x GPDX mice after 46 weeks of goitrogen treatment
Number of Number of
Tumour phenotype adenomas carcinomas
Uniformly positive 19 4
Uniformly negative 13 1
Mixed 0 0
Total 32 5
Figure la One large and two small adenomas (A) in an H and E
stained thyroid section from a heterozygous C3H x GPDX
mouse maintained on goitrogen until sacrifice. A small amount of
non-neoplastic, but radiation damaged thyroid tissue (N) can be
seen adjacent to the tumours. The size bar represents 100 j. b,
Serial section to Figure la stained with the histochemical tech-
nique for G6PD. Each of the adenomas (A) exhibits a single
enzyme phenotype, two positive and one negative, consistent with
a monoclonal origin. Both cellular phenotypes can be observed in
the background non-neoplastic thyroid (N). The size bar
represents 100 gm.
Figure 2 Thyroid follicular carcinoma with extracapsular vas-
cular invasion from a female mouse maintained on goitrogen
until sacrifice. H and E stained section. The size bar represents
50 tLm.
cells were large with regular vesicular nuclei (Figure a).
Fourteen carcinomas were observed, these were morpho-
logically similar to the adenomas, but showed capsular
invasion and permeation of extracapsular veins (Figure 2).
Non-neoplastic epithelium was present as small hyperplastic
follicles with the nuclear pleomorphism typical of radiation
damage.
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Animals withdrawnfrom goitrogen treatment 4 weeks prior to
sacrifice
Multiple lesions were again observed in all animals, the
average number of lesions per animal being 2.6 ± 1.8, with
a range from 1-7. Of a total of 73 counted, 72 were
adenomas and two were carcinomas. The decrease in the
number of carcinomas observed was statistically significant
(X2: P = <0.01; see Table I).
The decrease in the number of tumours in animals from
which goitrogen had been withdrawn was also accompanied
by a change in their morphology. The lesions showed a large
follicle pattern with abundant colloid, the follicular cells were
flattened with small, dark elongated nuclei and scanty cyto-
plasm. The regressive changes were present in both adenomas
and carcinomas and were also seen in the intravascular
tumour present in the carcinomas (Figure 3). Interestingly,
the marked nuclear pleomorphism characteristic of radiation
damage in the background thyroid was unaltered by goit-
rogen withdrawal.
Clonality ofinduced lesions
G6PD histochemsitry gave a uniform positive staining in the
TSH stimulated gland, but considerable intercellular
metabolic variation was observed in the non-TSH stimulated
gland of mice homozygous for normal levels of the enzyme.
(Thomas et al., 1988). For this reason, it is impractical to
determine clonality directly in the non-stimulated gland of
a
b
;8:.
Figure 3a Thyroid carcinoma induced by radiation and long-
term goitrogen treatment showing regression following 4 weeks
without goitrogen treatment prior to sacrifice. The lesion in this
H and E stained section is composed of colloid-filled follicles
lined by flattened, inactive epithelium, instead of the active fol-
licles seen in the tumours shown in Figures la and 2. The size bar
represents 50 jim. b, Another field from the same carcinoma as
3a, showing vascular invasion. The thyroid tissue within the
extrathyroid vessel shows similar features of regression to the
main tumour, demonstrating that invasion is compatable with
TSH responsiveness. H and E stained section. The size bar
represents 50 rim.
heterozygous animals. The clonality of lesions in this study
was therefore assessed in female heterozygous mice main-
tained on goitrogen until death.
All lesions observed in each of ten female mice heter-
ozygous for deficient G6PD activity showed uniform expres-
sion of a single enzyme phenotype (Figure lb). Thirty-seven
lesions were present in the median sections, five carcinomas
and 32 adenomas. Nineteen (59%) adenomas showed a posi-
tive enzyme phenotype and 13 (41%) a negative enzyme
phenotype. A previous study has predicted that if thyroid
tumours were to originate from more than two cells, a
minimum of 25% would express a mixed enzyme phenotype
(Thomas et al., 1989). The lack of any lesion with a mixed
enzyme phenotype confirms that the tumours in this study
are of a single cell origin. Four carcinomas expressed a
positive enzyme phenotype and one a negative enzyme
phenotype, suggesting that they too were monoclonal. Both
enzyme phenotypes were clearly separable in the background
non-neoplastic thyroid. All lesions in similarly treated
homozygous C3H mice showed the expected positive enzyme
phenotype, and all lesions in the homozygous GPDX mice
the expected negative enzyme phenotype, showing that there
was no significant alteration in enzyme expression associated
with neoplasia in this study.
Discussion
This study has shown that monoclonal thyroid lesions, both
adenomas and carcinomas, induced by a mutagen followed
by longterm goitrogen treatment regress when the goitrogen
is withdrawn. This regression is characterised by morpho-
logical changes and by a reduction in the number of tumours
observed - a very marked reduction in the case of the
carcinomas. Although we have not investigated the reap-
pearance of the malignant phenotype on reintroduction of a
high TSH, this has been shown in transplantation
experiments (Matovinovic et al., 1970).
The observation of regression in thyroid lesions has pre-
viously been interpreted as suggesting that they were hyper-
plastic rather than neoplastic (Todd, 1986). Jemec (1977) used
the term 'seeding of hyperplastic tissue' to describe pul-
monary lesions that accumulated colloid when goitrogen was
withdrawn. While our own findings of reversion to normal
phenotype agree with the earlier work, the additional
evidence we have provided showing that these lesions are
monoclonal must lead to a different explanation.
We now recognise that although tumours may initially be
monoclonal or oligoclonal they progress by clonal selection
(Nowell, 1978). While many different steps may be involved
during the progression of different thyroid tumours, a small
number of key steps are likely to be common to most spon-
taneous thyroid carcinomas. The normal follicular cell has
been shown to possess a growth limiting mechanism (Wyn-
ford-Thomas et al., 1982). The continued growth of tumour
cells infers that any such mechanism must have been lost in
neoplasia. Development of TSH independent growth is also
likely to be essential for spontaneous thyroid carcinogenesis.
The third key step is the acquisition of the ability to invade -
an essential feature of malignancy.
The development of these successive defects that lead to
neoplasia can be considered as a process of natural selection
at a cellular level; manipulation of the environment in which
the selection takes place will alter the selection process. In
experimental thyroid carcinogenesis, the induction of per-
sistently high TSH levels creates an environment in which
any cell which suffers a mutation (or epimutation) leading to
loss of its growth limiting mechanism will give rise to a clone
of cells which continue to grow and therefore continue to be
at risk of further mutation. As the normal cells continue to
be subjected to a maximum TSH stimulation, a mutation
leading to the development of TSH independent growth is
unlikely to confer any relative growth advantage or increased
risk of further mutation on the progeny of that cell. When
invasiveness develops in a cell that has not acquired TSH216 G.A. THOMAS et al.
independent growth, the resulting carcinomas retain TSH
dependency and will regress when the TSH stimulation is
withdrawn.
The individual mutations required for the development of
a carcinoma follicular key steps are not known. They repre-
sent three restriction points in the progression of a normal
follicular cell to a malignant follicular cell. The first step in
the sequence - the loss of the growth limitation mechanism -
may require two mutations as mechanisms of the antion-
cogene type are generally regarded as recessive. It has how-
ever recently been recognised that a single hit may lead to the
loss of an antioncogene through the synthesis of an altered
gene product that blocks the effect of the normal product
(Finlay et al., 1989).
A mechanism which may be relevant involves translocation
- already known to be important in other tumours, for
example in Burkitt's lymphoma (Dalla-Favera et al., 1982)
and chronic myelocytic leukaemia (Heisterkamp et al., 1983).
For the mechanism to be effective, a growth control gene
must be translocated to the region of an active promoter. In
the longterm stimulated follicular cell many genes are active,
both genes specifically related to thyroid function, like the
thyroglobulin gene, and housekeeping genes - as for example
G6PD. Prolonged TSH stimulation therefore increases the
chance that a translocation may occur to a promotionally
active site, with continued expression of the oncogene con-
cerned - but with little or no expression if the TSH stimula-
tion is withdrawn.
We suggest therefore that prolonged TSH stimulation may
obviate the need for the development of TSH independent
growth in carcinogenesis, and may also increase the chance
of excessive TSH dependent growth through translocation to
a TSH inducible promoter region. Whether one or both of
these mechanisms occurs, the method chosen in experimental
carcinogenesis to give a large number of tumours for study
may do this by by-passing one stage of the multistep process
normally required to generate the infrequent spontaneous
carcinomas of the thyroid seen in euthyroid man. Similar
principles may underlie models of experimental carcino-
genesis in other tissues, and tumours induced in man by
prolonged growth stimulation.
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